Functional Characterization of Myelodysplastic Syndrome by Multiparameter Flow Cytometry: The Clinical Synergy Between Ki-67 and Bcl-2 and Their Potential Role in Diagnostics and Personalized Therapy.

Wang SJ, Meel RAJNV, Mestrum SGC, Habets THPM, Hopman AHN, Ramaekers FCS, Henskens YMC, Bekers O, Leers MPG

Open source

DOI
10.3390/cancers18162648
Published
2026 Aug 17
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18162648,
  title = {Functional Characterization of Myelodysplastic Syndrome by Multiparameter Flow Cytometry: The Clinical Synergy Between Ki-67 and Bcl-2 and Their Potential Role in Diagnostics and Personalized Therapy.},
  author = {Wang SJ and Meel RAJNV and Mestrum SGC and Habets THPM and Hopman AHN and Ramaekers FCS and Henskens YMC and Bekers O and Leers MPG},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18162648},
  url = {https://doi.org/10.3390/cancers18162648}
}

RIS

TY  - JOUR
TI  - Functional Characterization of Myelodysplastic Syndrome by Multiparameter Flow Cytometry: The Clinical Synergy Between Ki-67 and Bcl-2 and Their Potential Role in Diagnostics and Personalized Therapy.
AU  - Wang SJ
AU  - Meel RAJNV
AU  - Mestrum SGC
AU  - Habets THPM
AU  - Hopman AHN
AU  - Ramaekers FCS
AU  - Henskens YMC
AU  - Bekers O
AU  - Leers MPG
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18162648
UR  - https://doi.org/10.3390/cancers18162648
ER  - 

APA

SJ, W., RAJNV, M., SGC, M., THPM, H., AHN, H., FCS, R., YMC, H., O, B., & MPG, L. (2026). Functional Characterization of Myelodysplastic Syndrome by Multiparameter Flow Cytometry: The Clinical Synergy Between Ki-67 and Bcl-2 and Their Potential Role in Diagnostics and Personalized Therapy.. Cancers. https://doi.org/10.3390/cancers18162648

Source records